110 related articles for article (PubMed ID: 28574782)
21. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
22. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways.
Chang MC; Chen CA; Chen PJ; Chiang YC; Chen YL; Mao TL; Lin HW; Lin Chiang WH; Cheng WF
Biochem J; 2012 Mar; 442(2):293-302. PubMed ID: 21999204
[TBL] [Abstract][Full Text] [Related]
23. Alteration in PI3K/mTOR, MAPK pathways and Her2 expression/amplification is more frequent in uterine serous carcinoma than ovarian serous carcinoma.
Mahdi H; Xiu J; Reddy SK; DeBernardo R
J Surg Oncol; 2015 Aug; 112(2):188-94. PubMed ID: 26250968
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I induces cyclooxygenase-2 expression via PI3K, MAPK and PKC signaling pathways in human ovarian cancer cells.
Cao Z; Liu LZ; Dixon DA; Zheng JZ; Chandran B; Jiang BH
Cell Signal; 2007 Jul; 19(7):1542-53. PubMed ID: 17341442
[TBL] [Abstract][Full Text] [Related]
25. The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions.
Schmitz U; Naderi-Meshkin H; Gupta SK; Wolkenhauer O; Vera J
Brief Bioinform; 2016 May; 17(3):380-92. PubMed ID: 26330575
[TBL] [Abstract][Full Text] [Related]
26. Long-noncoding RNAs in basal cell carcinoma.
Sand M; Bechara FG; Sand D; Gambichler T; Hahn SA; Bromba M; Stockfleth E; Hessam S
Tumour Biol; 2016 Aug; 37(8):10595-608. PubMed ID: 26861560
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA and Long Non-Coding RNA in Ovarian Carcinoma: Translational Insights and Potential Clinical Applications.
Ma Y; Lu Y; Lu B
Cancer Invest; 2016 Oct; 34(9):465-476. PubMed ID: 27673409
[TBL] [Abstract][Full Text] [Related]
28. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
29. Coordinately up-regulated genes in ovarian cancer.
Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
[TBL] [Abstract][Full Text] [Related]
30. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells.
Gao N; Nester RA; Sarkar MA
Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414
[TBL] [Abstract][Full Text] [Related]
31. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
[TBL] [Abstract][Full Text] [Related]
32. Identification of crucial regulatory relationships between long non-coding RNAs and protein-coding genes in lung squamous cell carcinoma.
Wu X; Ruan L; Yang Y; Mei Q
Mol Cell Probes; 2016 Jun; 30(3):146-52. PubMed ID: 26928440
[TBL] [Abstract][Full Text] [Related]
33. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
Yang Y; Du Y; Liu X; Cho WC
Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
[TBL] [Abstract][Full Text] [Related]
34. Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer.
Zhang L; Huang J; Yang N; Greshock J; Liang S; Hasegawa K; Giannakakis A; Poulos N; O'Brien-Jenkins A; Katsaros D; Butzow R; Weber BL; Coukos G
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5314-21. PubMed ID: 17875760
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs in Ovarian Cancer.
Katz B; Tropé CG; Reich R; Davidson B
Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
[TBL] [Abstract][Full Text] [Related]
36. In Systemic Sclerosis, a Unique Long Non Coding RNA Regulates Genes and Pathways Involved in the Three Main Features of the Disease (Vasculopathy, Fibrosis and Autoimmunity) and in Carcinogenesis.
Dolcino M; Tinazzi E; Puccetti A; Lunardi C
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30866419
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer.
Takeiwa T; Ikeda K; Horie-Inoue K; Inoue S
Front Cell Dev Biol; 2021; 9():641963. PubMed ID: 33996797
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Inducers of Apoptosis in Ovarian Cancer.
Binju M; Amaya-Padilla MA; Wan G; Gunosewoyo H; Suryo Rahmanto Y; Yu Y
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766284
[TBL] [Abstract][Full Text] [Related]
39. Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.
Shao Y; Li H; Du R; Meng J; Yang G
J Cancer; 2018; 9(11):1966-1972. PubMed ID: 29896281
[TBL] [Abstract][Full Text] [Related]
40. Single-Cell RNA Sequencing of Ovarian Cancer: Promises and Challenges.
Talukdar S; Chang Z; Winterhoff B; Starr TK
Adv Exp Med Biol; 2021; 1330():113-123. PubMed ID: 34339033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
